Researchers have developed a blood test using nanosensors to detect pancreatic cancer in its early stages, achieving 73% accuracy in identifying cancer cases and 98% accuracy in identifying healthy individuals. The test detects specific enzymes called proteases that are active in tumors, offering a potential breakthrough for early detection of a disease that claimed 467,000 lives globally in 2022.

https://www.nature.com/articles/d41586-025-00438-z

#medicalresearch #cancerdetection #nanotechnology #diagnostics #biotechnology